Results 61 to 70 of about 289,464 (193)

Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China [PDF]

, 2022
Jia Liu, Lidan Cao, Jing Wu
openalex   +1 more source

METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES

Фармакоэкономика, 2015
pharmacoeconomic cost-utility analysis – CUA is at third place by popularity (10% of studies) among studies of pharmacoeconomic analysis. Main stages of these trials are as follows: cost analysis, utility analysis and results assessment.
R. I. Yagudina, I. V. Sorokovikov
doaj  

Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19

Global & Regional Health Technology Assessment
Objective: This study aimed to estimate the cost-effectiveness of nirmatrelvir/ritonavir (NMV/r) versus the standard of care (SoC) for patients with mild-to-moderate coronavirus disease 2019 (COVID-19) at high risk for progression to severe illness from
Carolina Moreno, Andrea Aiello, Roberto Di Virgilio, Valentina Mazzotta, Andrea Antinori   +4 more
doaj   +1 more source

Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis [PDF]

, 2015
Robert Nee, Ian Rivera, Dustin J. Little, Christina M. Yuan, Kevin C. Abbott   +4 more
openalex   +1 more source

Cost-Utility Analysis of Community Case Management for Malaria Control in Burundi [PDF]

, 2022
Nina Hezagira, Sitaporn Youngkong, Arthorn Riewpaiboon   +2 more
openalex   +1 more source

Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain [PDF]

, 2017
Manuel Sánchez Luna, R. Burgos-Pol, Itziar Oyagüez, J. Figueras Aloy, Manuel Sánchez‐Solís, Federico Martinón‐Torres, Xavier Carbonell‐Estrany   +6 more
openalex   +1 more source

HTA31 Cost-Utility Analysis of Pneumococcal Vaccines for Older Adults Available in Costa Rica [PDF]

, 2023
Jordi Ordóñez‐Llanos, J.J. Baldi Castro   +1 more
openalex   +1 more source

Evaluation of physiotherapy using cost-utility analysis

Australian Journal of Physiotherapy, 1993
Limits on health care resources mean that resource allocation decisions should be guided by considerations of cost in relation to benefits. A method of economic evaluation, (cost-utility analysis) was used to evaluate the costs and benefits of a physiotherapy outpatient department.
openaire   +2 more sources

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study

ClinicoEconomics and Outcomes Research, 2020
Enrico Torre,1 Giacomo M Bruno,2 Sergio Di Matteo,2 Chiara Martinotti,2 Maria Chiara Valentino,2 Luigi C Bottaro,3 Giorgio L Colombo4 1Endocrinology Diabetology and Metabolic Diseases Unit - ASL3, Genoa, Italy; 2S.A.V.E.
Torre E, Bruno GM, Di Matteo S, Martinotti C, Valentino MC, Bottaro LC, Colombo GL   +6 more
doaj  

Cost-utility analysis of 5-fluorouracil and capecitabine for adjuvant treatment in locally advanced rectal cancer [PDF]

, 2018
Kanyarat Katanyoo, Imjai Chitapanarux, Tharatorn Tungkasamit, Somvilai Chakrabandhu, Marisa Chongthanakorn, Rungarun Jiratrachu, Lieutenant Col. Apiradee Kridakara, Kanokpis Townamchai, Pooriwat Muangwong, Chokaew Tovanabutra, Kittisak Chomprasert   +10 more
openalex   +1 more source